9:13 AM ET
Earnings Call
▶ Call
Becton, Dickinson and Earnings Call: Key Takeaways
BDX completed its transformation to a pure-play MedTech company, delivering 5.6% revenue growth in Q4 while navigating Alaris headwinds and significant tariff impacts through operational excellence and biologic drug delivery momentum.
- Call
- Nov 5, 2026, 6:30 AM ET